188 related articles for article (PubMed ID: 16166803)
1. Association between plasma adiponectin concentration and visceral fat accumulation in hemodialysis patients.
Odamaki M; Furuya R; Kinumura Y; Ikegaya N; Kumagai H
Nephron Clin Pract; 2006; 102(1):c8-13. PubMed ID: 16166803
[TBL] [Abstract][Full Text] [Related]
2. Relationship of high-molecular-weight adiponectin levels to visceral fat accumulation in hemodialysis patients.
Tamei N; Ogawa T; Ishida H; Ando Y; Nitta K
Intern Med; 2010; 49(4):299-305. PubMed ID: 20154435
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of metabolic syndrome and pulse wave velocity in hemodialysis patients: diagnosis of obesity by bioelectrical impedance analysis and a novel risk factor for atherosclerosis].
Sasaki N; Takeda S; Saito T; Ando Y; Kusano E
Nihon Jinzo Gakkai Shi; 2009; 51(4):476-83. PubMed ID: 19601557
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin Fractions Influence the Development of Posttransplant Diabetes Mellitus and Cardiovascular Disease in Japanese Renal Transplant Recipients.
Adachi H; Nakayama K; Hayashi N; Matsui Y; Fujimoto K; Yamaya H; Tonami H; Yokoyama H
PLoS One; 2016; 11(10):e0163899. PubMed ID: 27706207
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin and atherosclerosis risk factors in African hemodialysis patients: a population at low risk for atherosclerotic cardiovascular disease.
Amira OC; Naicker S; Manga P; Sliwa K; Mia A; Raal F; Crowther NJ; Immelman RA; Olorunju S
Hemodial Int; 2012 Jan; 16(1):59-68. PubMed ID: 22099423
[TBL] [Abstract][Full Text] [Related]
6. Relationship between abdominal fat accumulation and insulin resistance in hemodialysis patients.
Gohda T; Gotoh H; Tanimoto M; Sato M; Io H; Kaneko K; Hamada C; Tomino Y
Hypertens Res; 2008 Jan; 31(1):83-8. PubMed ID: 18360022
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin and cardiovascular outcomes among hemodialysis patients.
Abdallah E; Waked E; Nabil M; El-Bendary O
Kidney Blood Press Res; 2012; 35(4):247-53. PubMed ID: 22286012
[TBL] [Abstract][Full Text] [Related]
8. High visceral fat with low subcutaneous fat accumulation as a determinant of atherosclerosis in patients with type 2 diabetes.
Bouchi R; Takeuchi T; Akihisa M; Ohara N; Nakano Y; Nishitani R; Murakami M; Fukuda T; Fujita M; Minami I; Izumiyama H; Hashimoto K; Yoshimoto T; Ogawa Y
Cardiovasc Diabetol; 2015 Oct; 14():136. PubMed ID: 26445876
[TBL] [Abstract][Full Text] [Related]
9. Plasma adiponectin levels for prediction of cardiovascular risk among hemodialysis patients.
El-Shafey EM; Shalan M
Ther Apher Dial; 2014 Apr; 18(2):185-92. PubMed ID: 24720410
[TBL] [Abstract][Full Text] [Related]
10. Association of abdominal visceral adiposity and thigh sarcopenia with changes of arteriosclerosis in haemodialysis patients.
Kato A; Ishida J; Endo Y; Takita T; Furuhashi M; Maruyama Y; Odamaki M
Nephrol Dial Transplant; 2011 Jun; 26(6):1967-76. PubMed ID: 20980356
[TBL] [Abstract][Full Text] [Related]
11. Contribution of subcutaneous fat accumulation to insulin resistance and atherosclerosis in haemodialysis patients.
Gotoh H; Gohda T; Tanimoto M; Gotoh Y; Horikoshi S; Tomino Y
Nephrol Dial Transplant; 2009 Nov; 24(11):3474-80. PubMed ID: 19535435
[TBL] [Abstract][Full Text] [Related]
12. Association of Adiponectin With Body Composition and Mortality in Hemodialysis Patients.
Rhee CM; Nguyen DV; Moradi H; Brunelli SM; Dukkipati R; Jing J; Nakata T; Kovesdy CP; Brent GA; Kalantar-Zadeh K
Am J Kidney Dis; 2015 Aug; 66(2):313-21. PubMed ID: 25824125
[TBL] [Abstract][Full Text] [Related]
13. Increased subcutaneous fat accumulation has a protective role against subclinical atherosclerosis in asymptomatic subjects undergoing general health screening.
Narumi H; Yoshida K; Hashimoto N; Umehara I; Funabashi N; Yoshida S; Komuro I
Int J Cardiol; 2009 Jun; 135(2):150-5. PubMed ID: 18593641
[TBL] [Abstract][Full Text] [Related]
14. Potential impact of renin-angiotensin system inhibitors and calcium channel blockers on plasma high-molecular-weight adiponectin levels in hemodialysis patients.
Nakagawa N; Yao N; Hirayama T; Ishida M; Ishida H; Wada A; Fujino T; Saijo Y; Kikuchi K; Hasebe N
Hypertens Res; 2011 May; 34(5):592-8. PubMed ID: 21289628
[TBL] [Abstract][Full Text] [Related]
15. Association of high-molecular-weight to total adiponectin ratio with pulse wave velocity in hemodialysis patients.
Kato A; Odamaki M; Ishida J; Hishida A
Nephron Clin Pract; 2008; 109(1):c18-24. PubMed ID: 18493156
[TBL] [Abstract][Full Text] [Related]
16. Visceral fat level is an independent risk factor for cardiovascular mortality in hemodialysis patients.
Okamoto T; Morimoto S; Ikenoue T; Furumatsu Y; Ichihara A
Am J Nephrol; 2014; 39(2):122-9. PubMed ID: 24503580
[TBL] [Abstract][Full Text] [Related]
17. Altered abdominal fat distribution and its association with the serum lipid profile in non-diabetic haemodialysis patients.
Odamaki M; Furuya R; Ohkawa S; Yoneyama T; Nishikino M; Hishida A; Kumagai H
Nephrol Dial Transplant; 1999 Oct; 14(10):2427-32. PubMed ID: 10528668
[TBL] [Abstract][Full Text] [Related]
18. Association of serum adiponectin levels with all-cause mortality in hemodialysis patients.
Ohashi N; Kato A; Misaki T; Sakakima M; Fujigaki Y; Yamamoto T; Hishida A
Intern Med; 2008; 47(6):485-91. PubMed ID: 18344634
[TBL] [Abstract][Full Text] [Related]
19. Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women.
Drolet R; Bélanger C; Fortier M; Huot C; Mailloux J; Légaré D; Tchernof A
Obesity (Silver Spring); 2009 Mar; 17(3):424-30. PubMed ID: 19219061
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.
Zoccali C; Mallamaci F; Tripepi G; Benedetto FA; Cutrupi S; Parlongo S; Malatino LS; Bonanno G; Seminara G; Rapisarda F; Fatuzzo P; Buemi M; Nicocia G; Tanaka S; Ouchi N; Kihara S; Funahashi T; Matsuzawa Y
J Am Soc Nephrol; 2002 Jan; 13(1):134-141. PubMed ID: 11752030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
